Beroni Pharmaceutical has received approval from the Environmental Impact Report Form of the Zhuhai Ecological Environment Bureau

  • Post author:
  • Post category:2023
  • Post comments:0 Comments

The “Environmental Impact Report for the Anti-cancer Drug PENAO Project and Cell R&D and Transformation Project” (hereinafter referred to as the “Project”) submitted by the subsidiary of Beroni Group, Beroni…

Continue ReadingBeroni Pharmaceutical has received approval from the Environmental Impact Report Form of the Zhuhai Ecological Environment Bureau
Read more about the article Beroni Group was Invited to Attend the 4th World-Class Enterprises R&D and Innovation Management Forum
Group photo of guests

Beroni Group was Invited to Attend the 4th World-Class Enterprises R&D and Innovation Management Forum

  • Post author:
  • Post category:2023
  • Post comments:0 Comments

On September 8th, 2023, the “4th World-Class Enterprises R&D and Innovation Management Forum” was successfully held in Huabei Hotel, Hangzhou. Mr. Qingrui Xu, Academician of Chinese Academy of Engineering, Director…

Continue ReadingBeroni Group was Invited to Attend the 4th World-Class Enterprises R&D and Innovation Management Forum

Beroni and Shenyang University Of Chemical Technology Successfully Signed the Practice Base Agreement

  • Post author:
  • Post category:2023
  • Post comments:0 Comments

On March 31st, the signing ceremony of a Practice Base Agreement between Tianjin Beroni Biotechnology Co., Ltd., a subsidiary of Beroni Group and Shenyang University of Chemical Technology was held…

Continue ReadingBeroni and Shenyang University Of Chemical Technology Successfully Signed the Practice Base Agreement

Beroni Group Advances Research and Development of its Enhanced COVID-19 Antigen Rapid Test Kit

  • Post author:
  • Post category:2023
  • Post comments:0 Comments

On February 8, 2023, Beroni Group Limited (OTCQX: BNIGF; NSX: BTG) (“Beroni”), an Australia-based biopharmaceutical enterprise, announced that its enhanced COVID-19 Antigen Rapid Test Kit - Colloidal Gold Method has…

Continue ReadingBeroni Group Advances Research and Development of its Enhanced COVID-19 Antigen Rapid Test Kit
Read more about the article Beroni Pharmaceutical (Guangdong) Co., Ltd. Won the 3rd Prize of the Enterprise Group of Jingniuhui “Biomedical and Medical Devices” with the Innovative Drug for Advanced Solid Tumor Project
The award site of Beroni Pharmaceutical (Guangdong) Co., Ltd.

Beroni Pharmaceutical (Guangdong) Co., Ltd. Won the 3rd Prize of the Enterprise Group of Jingniuhui “Biomedical and Medical Devices” with the Innovative Drug for Advanced Solid Tumor Project

  • Post author:
  • Post category:2022
  • Post comments:0 Comments

The award site of Beroni Pharmaceutical (Guangdong) Co., Ltd. On December 19, 2022, the finals of the 8th “Jingniuhui” Venture Competition of Zhuhai Hi-tech Zone was launched in Zhuhai Hi-tech…

Continue ReadingBeroni Pharmaceutical (Guangdong) Co., Ltd. Won the 3rd Prize of the Enterprise Group of Jingniuhui “Biomedical and Medical Devices” with the Innovative Drug for Advanced Solid Tumor Project
Read more about the article Beroni Group Attending the Third TMU Pharmaceutical Forum and Annual Meeting of Pharmaceutical Branch of China National Health Association
Group photo

Beroni Group Attending the Third TMU Pharmaceutical Forum and Annual Meeting of Pharmaceutical Branch of China National Health Association

  • Post author:
  • Post category:2022
  • Post comments:0 Comments

On November 5, 2022, Beroni Group was invited to participate in the  “Third TMU Pharmaceutical Forum and Annual Meeting of Pharmaceutical Branch of China National Health Association”, which was sponsored…

Continue ReadingBeroni Group Attending the Third TMU Pharmaceutical Forum and Annual Meeting of Pharmaceutical Branch of China National Health Association